课题基金 / 基金详情

项目摘要

项目成果

JENNIFER A DOUDNA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
THE HARC CENTER: HIV ACCESSORY AND REGULATORY COMPLEXES GENETICS CORE SUMMARY To support all HARC Center Projects, the Genetics Core will provide innovative high-throughput methods for the discovery and functional characterization of HIV-host protein complexes in primary cells (i.e. activated primary CD4+ T cells, resting primary CD4+ T cells, and primary macrophages). Working in tandem with the Proteomics, Structural Biology, and Computational Cores, we will develop the HARC endogenous protein structure (HEPS) platform for the discovery and functional characterization of different HIV-host protein complexes by inserting affinity tags at genomic loci to allow affinity purification of endogenous protein complexes directly from HIV infected primary cells. Using our breakthrough CRISPR knock-out (CRISPRko), activation (CRISPRa), interference (CRISPRi), and knock-in (CRISPRki) technologies in primary human T cells, we will (1) generate a systematic map of proviral and antiviral HIV-interacting host factors, (2) functionally validate novel HIV-host interactions, (3) undertake endogenous deep mutational scanning of specific protein domains to identify critical host-pathogen interaction interfaces, and (4) introduce/replace small stretches of DNA at targeted genomic sites to study the function of specific genetic variants. Collectively, these genetic studies will strengthen the central HARC mission to understand interactions between HIV accessory proteins and host factors and open new experimental and therapeutic avenues for a broader HIV research community. In summary, the Genetics Core will develop a toolbox for genetic perturbations to complement innovative structural biology and proteomic efforts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats
  • 批准号:
    10668665
  • 项目类别:
  • 资助金额:
    $468.35万
  • 财政年份:
    2023
  • 负责人:
    JENNIFER A DOUDNA
  • 依托单位:
Cas9 RNP delivery to immune cells in vivo via molecular targeting
  • 批准号:
    10664098
  • 项目类别:
  • 资助金额:
    $125.74万
  • 财政年份:
    2022
  • 负责人:
    JENNIFER A DOUDNA
  • 依托单位:
Core 2
Identifying and inhibiting the SARS-CoV-2 packaging mechanism
  • 批准号:
    10204705
  • 项目类别:
  • 资助金额:
    $51.98万
  • 财政年份:
    2021
  • 负责人:
    JENNIFER A DOUDNA
  • 依托单位:
海外基金